contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


melissa-grant-joins-aegirbio-scientific-advisory-board

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Magnasense operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and mainly includes drugs for the treatment of multiple sclerosis. In addition to the main business, associated ancillary services are offered. The business is run in collaboration with other pharmaceutical actors, where the largest presence is found in the Nordic region.

Magnasense

Lund 8 July 2024 — AegirBio AB, a forefront leader in saliva-based diagnostics solutions, announces today that Melissa Grant, BSc, MSc, PhD, Associate Professor at the University of Birmingham...

<div class="mfn-preamble"><p><strong>Lund 8 July 2024 — AegirBio AB, a forefront leader in saliva-based diagnostics solutions, announces today that Melissa Grant, BSc, MSc, PhD, Associate Professor at the University of Birmingham’s School of Dentistry, has joined the company’s Scientific Advisory Board. Professor Grant brings a wealth of expertise in the biochemistry of saliva and its applications in disease detection.</strong></p></div><div class="mfn-body"><p>"We are thrilled to welcome Melissa Grant to our Scientific Advisory Board," said Marco Witteveen, CEO. "Her extensive research in biochemistry and her innovative approach to disease detection will be invaluable as we continue to advance our scientific initiatives."</p><p>Melissa Grant is co-lead of the Periodontal Research Group at the University of Birmingham and has published over 70 peer-reviewed scientific papers, reviews, and book chapters. Her research focuses on the use of proteomics for discovering novel biomarkers and understanding the mechanisms of inflammatory diseases, including those affecting the heart, oral cavity, and kidneys in humans and animals.</p><p>In addition to her research achievements, Professor Grant serves as the Postgraduate Research Lead, Equality, Diversity, and Inclusion Lead, and Curator of the Open Wide exhibition space at the School of Dentistry. She is also a dedicated Public Engagement Ambassador, furthering the reach and impact of her work within the community.</p></div><div class="mfn-footer mfn-contacts mfn-e503b60338ed"><p><strong class="mfn-heading-1">For additional information, please contact:</strong><br>Marco Witteveen, CEO, Aegirbio AB<br>Email: <a rel="noopener" href="mailto:ir@aegirbio.com">ir@aegirbio.com</a></p></div><div class="mfn-footer mfn-about mfn-8c31e8f3e677"><p><strong class="mfn-heading-1">About AegirBio</strong><br>AegirBio is a Swedish diagnostics company founded in 2019 to offer tests to monitor and optimize the dosage of biological drugs via its unique patented technology platform. In June 2020, AegirBio was listed on the Nasdaq First North Growth Market. The company's ambition is, in addition to bringing innovative diagnostic technology to the market, to make diagnostics more accessible, easier to use and to provide accurate and easily transferable results. For more information, see Aegirbio's website www.aegirbio.com</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/be04bd34-a389-4e32-b6a1-603693fd103f/melissa-grant-joins-aegirbio-scientific-advisory-board.pdf" class="mfn-generated mfn-primary">Melissa Grant joins AegirBio Scientific Advisory Board</a></p></div>

Melissa Grant joins AegirBio Scientific Advisory Board

Return on capital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Drug development investment: Value creation through M&As and licensing agreements

Income statement

Amazon and Costco in Sweden: A looming threat that Nordic retailers ignore at their peril

Stay up to date with our newsletter